Diosmetin
CAS 520-34-3
Diosmetin (CAS 520-34-3) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 14048.811428571427 nM | 27 | - |
| - | MIC | 24.875 ug.mL-1 | 8 | - |
| - | Potency | 7470.971428571429 nM | 7 | - |
| - | Ki | 40.333333333333336 nM | 3 | - |
| - | EC50 | 33840 nM | 2 | - |
| Multidrug resistance-associated protein 1 Transporter |
IC50 | 5.52 | - | Homo sapiens |
| Cytochrome P450 1B1 Enzyme |
IC50 | 7.54 | - | Homo sapiens |
| Lysine-specific histone demethylase 1A Enzyme |
IC50 | 4.55 | - | Homo sapiens |
| Inositol polyphosphate multikinase Kinase |
IC50 | 5.14 | - | Homo sapiens |
| Inositol hexakisphosphate kinase 2 Kinase |
IC50 | 6.05 | - | Homo sapiens |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| CYP1A1 CYP1A1 |
Inhibition | 7.050000190734863 pKi | 21482471 |
| CYP1B1 CYP1B1 |
Inhibition | 7.800000190734863 pKi | 21482471 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Diosmetin used for in pharmaceutical contexts?
Diosmetin (CAS 520-34-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Diosmetin?
No adverse-event association or SIDER side-effect rows are rendered for Diosmetin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Diosmetin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Diosmetin with EU status "permitted".
What clinical phase is Diosmetin in?
No phase 1-4 clinical development badge is rendered for Diosmetin because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Diosmetin?
Diosmetin has 10 bioactivity rows in this page query. Rendered target entries include Multidrug resistance-associated protein 1, Cytochrome P450 1B1, Lysine-specific histone demethylase 1A, Inositol polyphosphate multikinase, Inositol hexakisphosphate kinase 2.